Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RPT-GLOBAL MARKETS-World stocks near record peak, dollar stumbles again

Wed, 30th Dec 2020 10:20

(Repeats to change `Wrapup 3' to `Wrapup 4'. No change in
text.)

* World stocks up 14% this year, 70% from March lows

* Euro hits highest since April 2018 vs dollar

* AstraZeneca vaccine approval in Britain boosts UK assets

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

By Carolyn Cohn

LONDON, Dec 30 (Reuters) - World stocks edged closer to
recent record highs and Asian shares hit a record peak on
Wednesday, as investors bet on a strong economic recovery next
year, with the upbeat mood pushing the safe-haven dollar to its
lowest since April 2018.

Europe's main markets were hoping for a sixth straight
session of gains as AstraZeneca and Oxford
University's coronavirus vaccine became the second to be
approved by Britain, helping the FTSE 100 add as much as
0.2% early on.

A new, more transmittable variant of the virus is spreading
rapidly but European Union countries have also begun rolling out
Pfizer and BioNTech's vaccine this week.

Wall Street was set to open higher, too, with S&P 500
futures up 0.4%. U.S. stocks had retreated from an
intraday record high on Tuesday after Senate Majority Leader
Mitch McConnell had put off a vote on President Donald Trump's
call to increase COVID-19 relief checks.

The United States also detected its first-known case of the
new, highly infectious coronavirus strains already spotted in
Britain and South Africa.

MSCI’s world stocks index remained upbeat,
however, up 0.2% and within touching distance of the record
highs it had set on Tuesday.

The index is up 14% this year and nearly 70% from its March
lows, boosted by trillions of dollars in global economic
stimulus and hopes that coronavirus vaccines will re-open
locked-down economies.

"The prospect of more rapid and widespread inoculation will
be a shot of confidence to markets as the COVID-19 struggle
intensifies," said Janet Mui, investment director at wealth
manager Brewin Dolphin.

Away from the virus worries, British lawmakers were set to
vote on the UK-European Union trade deal later on Wednesday, a
day before a Brexit transition arrangement expires.

MSCI's gauge of Asia-Pacific shares excluding Japan
rose 1.4% to a record high, led by gains in
Chinese shares and bringing its gains this year to 19%.

Japan's Nikkei share average lost 0.45%, however, on
its last trading day of 2020 after jumping to a 30-year high on
Tuesday.

Conviction that global monetary authorities will continue to
pump liquidity into the banking system to support the
pandemic-stricken economy underpin risk assets.

Although many Republican Senators in the United States
remain adamantly opposed to increasing relief payments, support
is growing among them, including two from Georgia, who are
running in crucial races that will determine who will control
the Senate.

In currency markets, the dollar's weakness continued. It
dropped again on Wednesday, the first day where settlement of
trades will be in 2021.

The U.S. dollar index hit its lowest since April 2018
before recovering a little ground. It was last down 0.12%. The
euro reached its highest since April 2018 at close to $1.23.

"The start of COVID-19 immunization campaigns in several
countries as well as additional U.S. fiscal support reduce
downside risk to the global economy and bode well for general
financial market sentiment," analysts at Commonwealth Bank of
Australia said in a note.

The Australian dollar rose 0.6% to $0.7663, a
two-and-a-half-year high. Sterling traded up 0.34% at
$1.355. The Japanese yen also gained 0.25% to 103.28 per
dollar.

German 10-year bond yields - which move
inversely to price – gained 0.015 basis points. Oil prices
extended their recent climb on hopes stimulus and reopening of
economies next year will spur fuel demand.

U.S. West Texas Intermediate crude futures were up
0.73% at $48.35 a barrel. Gold was steady at
$1,878.5 an ounce.

(Editing by Larry King)

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.